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Association between depression and diabetes 
amongst adults in Bangladesh: Hospital–based 
case–control study 
Methods A matched case–control study was conducted among 591 
consecutive patients with diabetes attending a tertiary hospital in 
Dhaka and 591 controls matched for age, sex and area of residence 
without diabetes not related with the index–case. Depression was 
measured using the Patient Health Questionnaire–9. Multivariate lo-
gistic regression was performed to examine the association between 
depression and diabetes.
Results The mean age (±standard deviation) of the participants was 
50.4 ± 11.4 years, with a male to female ratio of 43:57. The prevalence 
of depression was 45.2% and 19.8% among cases and controls, re-
spectively. In the multivariate analysis, mild as well as moderate to 
severe depression were significantly associated with diabetes and in-
dependent of sociodemographic factors and co–morbidity (adjusted 
odds ratio (OR) = 2.0, 95% confidence interval (CI) = 1.4–2.9 and ad-
justed OR = 6.4, 95% CI = 3.4–12.3; P < 0.001 for both).
Conclusion The high prevalence and strong association of depres-
sion in individuals with diabetes in Bangladesh suggests that depres-
sion should be routinely screened for patients with diabetes at the 
clinics and that management strategies adequate for resource–poor 
settings need to be developed. Further research to determine the 
pathophysiological role of depression in the development of diabetes 
is merited.
Diabetes and depression are two major non–communicable diseases 
which have become global epidemics and cause significant mortality and 
morbidity [1–3]. Worldwide, there are 382 million people with diabetes 
and within next two decades this number is projected to increase to 592 
million with an increasing trend in the younger population [1]. The In-
ternational Diabetes Federation (IDF) estimated that in 2013, diabetes 
caused 5.1 million deaths and cost US$ 548 billion in health care spend-
ing [1]. Diabetes is a major global cause of premature mortality, reduced 
quality of life, and imposes huge social and economic impact on health 
care systems, households and nations as a whole [1]. The global burden 
of disease study predicted that by 2030, depression is set to become the 
leading disease with 6.3% of the overall disease burden, and diabetes will 
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The BIHS is a 500–bed national–level tertiary health care 
covers all disciplines of medicine under a single roof hav-
ing modern biomedical laboratory and research institute 
for diabetes affiliated with the Diabetes Association of Ban-
gladesh and World Diabetic Federation. The OPD of BIHS 
hospital has one of the largest diabetes patient’s turnover 
in Bangladesh and serves a diverse population of about 2.2 
million in Dhaka city and nearby districts.
Data collection process
Data were collected by a team consisting of one project re-
search physician, one research officer and three research 
assistants experienced in hospital data collection. The team 
was trained for 4 weeks on diabetes epidemiology, study 
design, study aims and objective, interview skills, research 
ethics, anthropometric and blood pressure measurements. 
The research tools and instruments were developed by the 
Health Economic Group of the International Diabetes Fed-
eration (IDF) and translated into Bengali as per WHO stan-
dards of translating and back–translating. The question-
naires were pre–tested in a similar setting in BIRDEM 
hospital OPD for 25 cases and 25 control subjects. Feed-
back from the field testing was used to improve the lan-
guage and contents of the questionnaire and tools.
The questionnaire contained information about socio–de-
mographic factors such as age, sex, marital status, educa-
tion, occupation, income, history of depression, diabetes, 
family history of diabetes, smoking history, and self–re-
ported complications (eye, hypertension, cardiovascular 
diseases, kidney diseases, etc). Weight, height, and hip and 
waist circumference were measured using standard proto-
col. Blood pressure was measured using digital blood pres-
sure monitor (Omron, SEM–1, Omron Corporation, Ja-
pan). Two repeated measurements were recorded after an 
interval of 5 minutes, alternating right and left hands and 
the average of two readings was considered. Hypertension 
was defined as systolic blood pressure (SBP)140 mm Hg 
and/or diastolic blood pressure (DBP)90 mm Hg as per 
JNC 7 guideline. Blood tests on HbA1c were measured at 
the BIHS Research Laboratory.
Level of depression was measured using the Patient Health 
Questionnaire (PHQ–9) which consists of nine items on a 
4–point Likert–type scale with scores ranging from 0–27 
corresponding to the Diagnostic and Statistical Manual of 
Mental Disorder (DSM–IV) diagnostic criteria for major de-
pressive disorder [17]. Depression scores of 0–4, 5–9, and 
10 was used to classify minimal, mild and moderate to 
severe depression, respectively [18]. The PHQ–9 is one of 
the most widely used depression screening tools in prima-
ry health care and a cut–off score of 10 has shown to have 
88% sensitivity and 88% specificity to diagnose major de-
pression [19]. In this study we used a previously developed 
be in 10th place with 2.3% of the overall disease burden as 
a percentage of the overall disability adjusted life years [4].
Diabetes and depression often present together and repre-
sent a major clinical challenge as the outcome of each con-
dition can be worsened by the other [5]. Several studies 
have reported that comorbid diabetes and depression pro-
duced the greatest level of disability compared to other 
conditions, predicted sub–optimum outcomes, and in-
curred higher health care costs that increased with depres-
sion severity [6–9]. Despite high rates of comorbid depres-
sion in patients with diabetes, depression is often 
unrecognized and untreated in approximately two–thirds 
of patients in primary care settings [10].
The prevalence of both diabetes and depression are increas-
ing in Southeast Asia [11]. Previous studies in Bangladesh 
have reported that the prevalence of depression among pa-
tients with diabetes was between 15.3–36% [12–15]. How-
ever, two of these studies had no control group [13–15] 
whereas the other two were population–based studies with 
relatively small numbers of incident cases of diabetes and 
insufficient data to examine sociodemographic and other 
factors potentially influencing the association of depression 
and diabetes [12,14]. Based on the data available, it is dif-
ficult to appreciate the true magnitude of the problem of 
depression among individuals with diabetes in Bangladesh 
as well as exclude important confounding factors. To close 
these knowledge gaps, we conducted a matched case–con-
trol study of individuals with and without diabetes at a 
large outpatient treatment facility in the Bangladeshi capi-
tal city, Dhaka. We hypothesized that persons with diabetes 
would have higher prevalence of depression than persons 
without diabetes.
METHODS
Study design, population and place
We conducted a matched case–control study among 1182 
participants from January to July 2014 in the outpatient 
department (OPD) of the Bangladesh Institute of Health 
Sciences (BIHS) hospital. Detailed methods have been pub-
lished elsewhere [16]. In brief, 591 consecutive patients 
with diabetes diagnosed by the BIHS attending physicians 
were recruited as cases. For each index–case, we recruited 
one control matched for age (±5 years), sex and area of res-
idence from the persons accompanying other patients in 
the OPD waiting room. All individuals aged between 20–
60 years were eligible for the study. Inclusion criteria for 
cases were: diagnosis of diabetes according to WHO crite-
ria by attending BIHS physician. We excluded participants 
who were pregnant, had a terminal illness such as cancer 
or required urgent medical attention.
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and evaluated Bengali version of PHQ–9. The PHQ–9 and 
its cut–off points have been validated in Bangladeshi pop-
ulation and considered to be reliable tool for diagnosis of 
depression [13].
Data analysis
Data were entered into a Microsoft Access database with 
built–in range and consistency checks and analyzed using 
SPSS version 20 (IBM Corporation, NY, USA). Frequencies 
and percentages were calculated for categorical variables 
and mean±SD and median (Q1–Q3) were calculated for 
normality distributed and non–normally distributed con-
tinuous variable. T–test, χ2 and Mann-Whitney U tests were 
performed for differences between cases and controls. Uni-
variate analysis was performed with diabetes as the dichot-
omous outcome variable. The category of the independent 
variable with the minimum level of association with diabe-
tes was taken as reference value. Conditional logistic regres-
sion was performed to evaluate the association of depres-
sion and other independent variables with diabetes. Odds 
ratios (OR) are reported with their respective 95% confi-
dence intervals (CI) and P–value. A P–value of less than 
0.05 was considered significant.
RESULTS
A total of 1265 participants were approached for this study 
and 1240 (98%) agreed to participate. Of those, 40 indi-
viduals were not included in the study (15 controls who 
had a history of diabetes, 8 cases who were pregnant, 17 
cases who had no medical records available at the time of 
data collection). Another 18 participants were excluded 
before data analysis due to matching problems and incom-
plete information. The final sample therefore consisted of 
1182 participants.
Characteristics of the study participants
The study included 1182 participants with a male to female 
ratio of 43:57 and mean age (±standard deviation) of 
50.4 ± 11.4 years. The majority of the participants were 
married and Muslims. About two–thirds of the participants 
completed secondary education or higher. About half of 
the participants were housewives, and one–third were ser-
vice holders or businessmen. The overall median (Q1–Q3) 
household income was BDT 25 000 (15 000–60 000) or 
US$ 323.42 (194.05–776.20) and about two–thirds earned 
BDT 30 000 (US$ 388.10) or less per month (US$ 1 = BDT 
77.3, 2014). Self–reported complications generally associ-
ated with diabetes (hypertension, cardiovascular diseases 
(CVD) and eye problems) were significantly higher among 
persons with diabetes than persons without diabetes 
(52.8% vs 19.3%, 10% vs 3.4% and 60.1% vs 38.1% re-
spectively). Current tobacco use was higher among persons 
without diabetes than persons with diabetes (P = 0.04). The 
prevalence of hypertension measured by systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) was 
higher for persons with diabetes than persons without dia-
betes (35.2% vs 28.1%, P = 0.009). Waist circumference 
and waist–hip ratio was significantly higher for persons 
with diabetes than persons without diabetes. Persons with 
diabetes also had a higher number of complications than 
persons without diabetes (1.76 ± 1.2 vs 2.05 ± 1.34). Per-
sons with diabetes reported taking higher number of med-
ication than persons without diabetes (3.67 ± 1.76 vs 
1.79 ± 1.07) (Table 1).
Prevalence of depression
The prevalence of depressive illness was found higher 
among persons with diabetes (28.3%) than persons with-
out diabetes (16.9%; P < 0.001). The prevalence of moder-
ate to severe depression was 16.9% in persons with diabe-
tes vs 2.9% in persons without diabetes (P < 0.001) (Table 
1 and Figure 1).
Association between diabetes and 
depression
Table 2 shows the univariate analysis of factors associated 
with diabetes with unadjusted OR and 95% CI. No depres-
sion or minimal and moderate to severe depression were 
significantly associated with diabetes (OR = 2.7, 95% 
CI = 2.0–3.8) and (OR = 9.9, 95% CI = 5.4–18.0), respec-
tively. Other factors found to be significantly associated 
with diabetes were age 40 years, secondary and higher 
education (inverse association), housewife or other occu-
pation (such as retirees, day laborers), marital status single, 
obesity, hypertension and having higher number of com-
plications (Table 2).
Figure 1. Prevalence of depression among study participants 
using PHQ–9.
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Table 1. Characteristics of study participants
Variables Case
n = 591
Control
n = 591
total
n = 1182
P–Value
n % n % n %
Age (years):
Mean±SD 51.4 ± 11.6 49.5 ± 11.1 50.4 ± 11.4 0.004
<40 96 16.2 115 19.5 211 17.9 0.027
40–49 142 24.0 144 24.4 286 24.2 0.027
50–59 194 32.8 215 36.4 409 34.6 0.027
 60 159 26.9 117 19.8 276 23.4 0.027
Sex
Male 255 43.1 255 43.1 510 43.1 1.0
Female 336 56.9 336 56.9 672 56.9 1.0
Marital status:
Married 476 80.5 517 87.5 993 84.0 0.001
Single 115 19.5 74 12.5 189 16.0 0.001
Education:
No education 116 19.6 76 12.9 192 16.2 0.001
Primary 103 17.4 96 16.2 199 16.8 0.001
Secondary 190 32.1 178 30.1 368 31.1 0.001
Higher secondary and above 182 30.8 241 40.8 423 35.8 0.001
Household monthly income (BDT):
Median (in thousands) (Q 1–3) 25 (15–42) 25 (16–40) 25 (15–60) 0.714
BDT 30 000 338 63.7 353 63.8 691 63.7 0.951
>BDT 30 000 193 36.3 200 36.2 393 36.3 0.951
Occupation:
Unemployed 6 1.0 9 1.5 15 1.3 <0.001
Service 170 28.8 248 42.0 418 35.4 <0.001
Housewife 309 52.3 271 45.9 580 49.1 <0.001
Others (retired, labors, etc) 106 17.9 63 10.7 196 14.3 <0.001
Self–reported complications:
Hypertension 312 52.8 114 19.3 426 36.0 <0.001
Cardiovascular diseases (CVD) 59 10 20 3.4 79 6.7 <0.001
Eye problems 355 60.1 225 38.1 580 49.1 <0.001
Tobacco use:
Never 471 79.7 445 75.3 916 77.5 0.040
Former (stopped 6 months) 6 1.0 2 0.3 8 0.7 0.040
Current (in last 6 months) 114 19.3 144 24.4 258 21.8 0.040
Depression (PHQ–9):
No or minimal depression (0–4) 324 54.8 474 80.2 798 67.5 <0.001
Mild depression (5–9) 167 28.3 100 16.9 267 22.6 <0.001
Moderate to severe depression (10) 100 16.9 17 2.9 117 9.9 <0.001
Hypertension (SBP>140 /or DBP>90): 208 35.2 166 28.1 374 31.6 0.009
Body Mass Index (BMI):
Underweight (<18.5 kg/m2) 9 1.5 18 3.1 27 2.3 0.071
Normal (18.5 –24.9 kg/m2) 219 37.1 235 39.9 454 38.5 0.071
Overweight (25–29 kg/m2) 274 46.4 271 46.0 545 46.2 0.071
Obese (30 kg/m2) 88 14.9 65 11 153 13.0 0.071
Waist circumference (WC):
Normal (90 cm M; 80 cm F) 154 26.1 215 36.4 369 31.2 <0.001
High (>90 cm M, >80 cm F) 437 73.9 376 63.6 813 68.8 <0.001
Waist–to–hip ratio (WHR):
Normal (<0.90 M, <0.80 F) 29 4.9 55 9.3 84 7.1 0.003
High (0.90 M, 0.80 F) 562 95.1 536 90.7 1098 92.9 0.003
Number of complications:
No complication 91 15.4 240 40.6 331 28.0 <0.001
1–3 451 76.3 328 55.5 779 65.9 <0.001
>3 49 8.3 23 3.9 72 6.1 <0.001
Median (IQR) 2 (2) 2 (2) 2 (2) <0.001
Number of medications:
1–2 157 27.2 98 80.3 255 36.4 <0.001
3–4 259 44.8 21 17.2 280 40.0 <0.001
>4 162 28.0 3 2.5 165 23.6 <0.001
Median (IQR) 3 (3) 1 (1) 3 (2) <0.001
SD – standard deviation, IQR – interquartile range, Q – quartile, BDT – Bangladeshi Taka, PHQ – Patient Health Questionnaire, SBP – systolic blood 
pressure, DBP – diastolic blood pressure, M – male, F – female, BMI – body mass index (kg/m2)
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Table 3 presents the results of conditional logistic regres-
sion analyses for factors associated with diabetes after ad-
justing for confounders. No depression or minimal and 
moderate to severe depression were significantly associated 
with diabetes (OR = 2.0, 95% CI = 1.4–2.9) and (OR = 6.4, 
95% CI = 3.4–12.3) respectively. Having 1–3 complications 
(OR = 3.1, 95% CI = 2.2–4.4), 3 complications (OR = 3.1, 
95% CI = 1.5–6.2), other occupations (OR = 4.9, 95% 
CI = 1.3–18.0) and completing higher secondary education 
and above (OR = 0.52, 95% CI = 0.3–0.8) were also signifi-
cantly associated with diabetes, controlling for other con-
founding variables.
DISCUSSION
This study, to the best of our knowledge, is the first matched 
case–control study determining the prevalence of depres-
sion among people with and without diabetes in Bangla-
desh that also measures the association between depression 
and diabetes. Our study showed that depression, particu-
larly in a moderate to severe form, is much more common 
among those with diabetes than those without the disease. 
In addition, we found that the association of depression 
and diabetes is independent of socio–demographic factors 
and diabetes–associated complications.
Several longitudinal studies have reported that increased 
depressive symptoms at baseline are associated with inci-
dent type 2 diabetes [7,20,21]. Several factors associated 
with depression, such as physical inactivity, hypercaloric 
diet, neuroendocrine and inflammatory responses result-
ing in increased cortisol, catecholamines, and cytokines can 
induce insulin resistance leading to the development of 
diabetes [7]. A meta–analysis showed that the risk of de-
Table 2. Univariate analysis of factors associated with diabetes
Variables odds ratio 
(or)
ConfidenCe 
interVal
P–Value
Depression:
Minimal depression (0–4) Ref
Mild depression (5–9) 2.7 2.0–3.8 <0.001
Moderate to severe depression (10) 9.9 5.4–18.0 <0.001
Education:
No education Ref
Primary 0.7 0.5–1.1 0.093
Secondary 0.7 0.5–1.0 0.034
Higher secondary and above 0.5 0.3–0.7 <0.001
Age:
<40 Ref
40 4.2 1.7–10.2 0.002
Household monthly income (BDT):
BDT 30 000 Ref
>BDT 30 000 1.0 0.8–1.3 0.842
Occupation:
Unemployed Ref
Service 1.1 0.4–3.2 0.876
Housewife 3.1 1.0–9.6 0.048
Others (retired, labors, etc) 3.2 1.0–9.7 0.046
Marital status:
Married Ref
Single 1.7 1.2–2.4 0.001
BMI:
Underweight (<18.5 kg/m2) 0.5 0.2–1.2 0.098
Normal (18.5–24.9 kg/m2) Ref
Overweight (25–29.9 kg/m2) 1.1 0.9–1.4 0.435
Obese (30 kg/m2) 1.5 1.0–2.1 0.044
Hypertension:
Absent Ref
Present 1.4 1.1–1.8 0.009
Number of complications:
No complication Ref
1–3 4.0 2.9–5.6 <0.001
>3 6.7 3.7–12.0 <0.001
BMI – body mass index (kg/m2)
Table 3. Conditional logistic regression analyses for factors 
associated with diabetes
Variables odds ratio 
(or)
ConfidenCe 
interVal
P-Value
Depression:
No or minimal depression (0–4) Ref
Mild depression (5–9) 2.0 1.4–2.9 <0.001
Moderate to severe depression (10) 6.4 3.4–12.3 <0.001
Age (years):
<40 Ref
40 1.71 0.65–4.47 0.278
Education:
No education Ref
Primary 0.76 0.46–1.24 0.27
Secondary 0.76 0.48–1.19 0.22
Higher secondary and above 0.52 0.33–0.83 0.01
Occupation:
Unemployed Ref
Service or business 1.70 0.49–5.83 0.4
Housewife 3.67 0.98–13.75 0.05
Others 4.92 1.345–18.00 0.02
Marital status:
Married Ref
Single 1.50 1.00–2.26 0.05
BMI:
Underweight (<18.5 kg/m2) 0.32 0.11–0.96 0.04
Normal (18.5–24.9 kg/m2) Ref
Overweight (25 –29.9 kg/m2) 1.14 0.83–1.55 0.42
Obese (30 kg/m2) 1.36 0.85–2.17 0.2
Hypertension:
Absent Ref
Present 1.24 0.91–1.68 0.17
Number of complications:
No complication Ref
1–3 3.07 2.15–4.38 <0.001
>3 3.06 1.52–6.17 0.002
BMI – body mass index (kg/m2)
www.jogh.org •  doi: 10.7189/jogh.05.020406	 5	 December 2015  •  Vol. 5 No. 2 •  020406
V
IE
W
PO
IN
TS
PA
PE
RS
Islam et al.
veloping type 2 diabetes was 37% higher in depressed 
adults than in non–depressed adults [22].
Conversely, the psychosocial demands of diabetes manage-
ment, lifestyle change, incidence of complications and re-
sulting functional impairment may influence depression 
severity, decrease quality of life, and contribute to pro-
longed or recurrent episodes of depression [23]. Depres-
sion in patients with chronic illness might cause nonspe-
cific amplification of physical symptoms associated with 
the medical condition [24]. Compared to non–depressed 
patients, patients with major depressive disorders were 2 
to 5 times more likely to report the presence of 10 diabet-
ic symptoms after controlling for a number of diabetes 
complications [25]. These results are in line with our find-
ings of an increased number of complications associated 
with diabetes which might lead to or aggravate depression.
Depressive symptoms are associated with decreased glyce-
mic control and increased diabetic complications, which 
worsen depression and lessen response to antidepressant 
treatment [26]. Previous studies have shown that the cor-
relation between depression and poor diabetic self–care is 
consistent across diverse socioeconomic and cultural 
groups [27,28]. Comorbid depression in patients with di-
abetes is also associated with increased numbers and sever-
ity of diabetic symptoms and complications [29,30]. A 
meta–analysis demonstrated a clinically significant relation 
between depression and several diabetic complications 
[31]. Our results show that patients with more complica-
tions had 3 times the odds to be significantly associated 
with diabetes.
Previous studies have shown that type 2 diabetes is associ-
ated with an increased risk of depressive symptoms [32,33]. 
A Bangladeshi study reported 31.6% of comorbid depres-
sion among patients with type 2 diabetes while the preva-
lence of depression in persons without diabetes was 12.6%, 
which is similar to our findings [14]. Another study in Ban-
gladesh reported 36.2% of participants with moderate to 
severe depression, which was significantly higher among 
females [34]. A worldwide survey by WHO reported that 
9.3% of patients with diabetes also had depression [6]. A 
meta–analysis reported that people with type 2 diabetes 
have a 24% increased risk of incident depression compared 
with people without diabetes [35]. A study in China re-
ported that depression was three times higher among per-
sons with diabetes compared to those without diabetes 
[36]. Our results show a much higher prevalence of depres-
sive symptoms among patients with diabetes compared to 
previous studies in Bangladesh, which might be due to se-
lection of samples from a specialized hospital as well as the 
use of different scale and cut–off values to measure depres-
sion. Also, participants with moderate to severe depression 
in our study had 6.4 times higher odds of having diabetes, 
which is almost double what is reported by a study from 
China [36].
A recent systematic review reported that the prevalence of 
depression among individuals with diabetes is higher in 
population with low socioeconomic status in low–and–
middle–income countries. However, the available evidence 
base was small [10]. We found that the association of dia-
betes and depression was independent of an individual’s 
education and household income in our sample. Addition-
ally, it was not affected by other socio–demographic factors, 
BMI, hypertension, or the number of diabetes–associated 
complications.
Even in well–funded health care systems, depression is un-
der diagnosed and undertreated in individuals with diabe-
tes [5]. In Bangladesh, where there is a shortage of trained 
workforce in mental health and diabetes, patients with co-
morbid diabetes and depression are even less likely to re-
ceive adequate management for both conditions [37]. This 
may contribute to the fact that diabetes management in 
Bangladesh is suboptimal even in the best clinical settings, 
and the majority of the patients present with high rates of 
complications [38].
Strengths and limitations
The strength of this study is the matched case–control de-
sign which controlled for the age, sex and area of residence 
of the study participants during the recruitment stage. Both 
case and controls were recruited at the same time, under 
similar conditions, by the same research assistants and from 
the same source population reducing confounding bias. 
The limitations of this study include that controls were se-
lected on the basis of self–reported absence of diabetes, 
which could not be verified by laboratory investigations. 
However, our study physician ensured that the controls 
were not on any anti–diabetic medications. We used PHQ–
9 which was not designed to measure clinical depression. 
However, PHQ–9 is an efficient and valid tool and has been 
commonly used to identify depression in primary health 
care in previous studies [13,39]. Furthermore, we mea-
sured depression at a single–time point and did not con-
sider the use of antidepressants, which might have misclas-
sified our participants. Finally, our data on complications 
are self–reported by participants for cardiovascular diseas-
es, eye problems and kidney diseases which could not be 
verified by clinical or laboratory investigations. They were 
however verified to the extent possible by a review of the 
participants’ medical records. Well–designed longitudinal 
studies with objective measurements of clinical complica-
tions and measures of neuroendocrine markers will help to 
establish the direction of association and pathophysiology 
of both depression and diabetes among the Bangladeshi 
population.
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CONCLUSION
The prevalence of depression, particularly moderate to se-
vere, is very high among adult Bangladeshis with diabetes. 
Therefore, patients with diabetes should be routinely 
screened for depression in Bangladesh and probably simi-
lar other developing countries. Management strategies and 
guidelines adequate for the country level need to be devel-
oped and further research to determine the pathophysio-
logical role of depression in the development of diabetes in 
Southeast Asians is merited.
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